OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
Condition:   Opioid-use Disorder Interventions:   Device: OXD01 digital therapy;   Other: Standard of Care Sponsor:   Orexo AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2021 Category: Research Source Type: clinical trials

Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
Condition:   Opioid-use Disorder Intervention:   Drug: Buprenorphine/naloxone Sponsor:   University of British Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2021 Category: Research Source Type: clinical trials